According to MarketsandMarkets™, the global pharmaceutical manufacturing equipment market is projected to reach USD 21.24 billion in 2026 and USD 30.39 billion by 2032, exhibiting a CAGR of 6.2% ...

According to MarketsandMarkets, the global pharmaceutical manufacturing equipment market is projected to reach USD 21.24 billion in 2026 and ...

The large molecule drug substance CDMO market is projected to grow at a CAGR of approximately 9% over the forecast period.

After UCB’s Bimzelx scored five approvals in just two years, the Belgian drugmaker has quickly made a blockbuster out of its up-and-coming immunology powerhouse. | Two years and five indications later ...

The Gene Synthesis Market has emerged as one of the most transformative segments within modern biotechnology, driven by rapid ...

The global mental health software market is experiencing sustained expansion; valued at $4.8 billion in 2023, the market is projected to grow to $14.6 billion by 2033, reflecting a steady CAGR of 11.7 ...

PRNewswire/ - According to MarketsandMarkets™, the global Location-based Services (LBS) and Real-time Location Systems (RTLS) Market size will grow to ...

Rise in awareness about mental health is one of the major factors that foster the growth of the market. It helps foster scalable systems to manage records, appointments, and treatment plans ...

This article explores current OSD development and manufacturing trends from a CDMO perspective, including the evolution of outsourcing, emerging technologies, manufacturing advancements and industry ...

Expands Quotient's capabilities for handling and manufacturing highly potent API (HPAPI) drug molecules and products.

Contract work opportunities have grown year over year, and recent reports show more people are in this type of role, according to BioSpace data. Three biopharma professionals share why they’ve become ...